About two weeks ago, we reported that Jatinder Ahluwalia — a scientist at the University of East London (UEL) who had been found guilty of scientific misconduct at University College London (UCL) — had been dismissed from the University of Cambridge’s graduate studies program for data fabrication. A dean at UEL told us later that week that the university was looking into the situation, and the lack of progress and communication from senior officials apparently has the faculty in an uproar. Continue reading Ahluwalia did not tell UCL he had been dismissed from Cambridge
Category: misconduct investigations
Exclusive: UEL staff “in uproar about lack of progress” investigating Jatinder Ahluwalia
On Friday, we reported that the University of East London (UEL) was looking into the career of Jatinder Ahluwalia, the UEL researcher who has left a trail of alleged scientific misconduct at Cambridge University and University College London.
Today, in another Retraction Watch exclusive, we have obtained a letter sent by a faculty member at UEL to department colleagues. It suggests that faculty there are very concerned about the toll these allegations may take on the university’s students and reputation, and are furious that senior officials have failed to keep them in the loop about any potential investigation.
Here’s the text of the letter: Continue reading Exclusive: UEL staff “in uproar about lack of progress” investigating Jatinder Ahluwalia
University of East London “looking into” Jatinder Ahluwalia’s career
We’re continuing to follow the case of Jatinder Ahluwalia. As we reported on Tuesday, Ahluwalia was dismissed from graduate school at the University of Cambridge years before a University College London (UCL) investigation found had renumbered files to deceive a co-author, and had likely sabotaged his colleagues’ work while manipulating his solutions to improve how his results looked. The results of that investigation came to light as part of a Nature retraction.
Ahluwalia now works — and studies plagiarism, in fact — at the school of health and bioscience at the University of East London. We asked Neville Punchard, the school’s dean, whether the university was aware of Ahluwalia’s past. Punchard replied by email: Continue reading University of East London “looking into” Jatinder Ahluwalia’s career
Unglaublich! Boldt investigation may lead to more than 90 retractions
Self-plagiarism alert: A very similar version of this post is being published online in Anesthesiology News, where one of us (AM) is managing editor.
Unglaublich is the German word for unbelievable, and it’s an apt description for the latest development in the case of Joachim Boldt.
Boldt, a prominent German anesthesiologist, has been at the center of a research and publishing investigation since last October, when the journal Anesthesia & Analgesia retracted a 2009 article of his over concerns of data manipulation. This morning, the German medical board overseeing the case, the Landesärztekammer Rheinland-Pfalz (LÄK-RLP), released its findings — and they are truly stunning.
According to LAK, somewhere in the neighborhood of 90 of Boldt’s published articles might require retraction because the investigator failed to obtain approval from an institutional review board to conduct the research.
We don’t read German. But, fortunately, the LÄK-RLP announcement was accompanied by a joint letter posted to the websites of 11 major anesthesia journals. We do read English, and here’s what that letter says: Continue reading Unglaublich! Boldt investigation may lead to more than 90 retractions
Researcher found to have deceived colleague — and perhaps sabotaged others — decides to study plagiarism
Jatinder Ahluwalia apparently did some pretty bad things as a researcher at University College London. As we reported in November, in an investigation related to a Nature retraction, a research misconduct panel at UCL found that:
Ahluwalia “renumbered the files to deceive [another coauthor,] Professor [Lucie] Clapp as to the results of his patch clamping experiments,” adulterated his reagents so his results would look better, and sabotaged his colleagues’ work.
The panel said that the file renumbering charge was proven “beyond reasonable doubt,” and “that on the balance of probabilities it was highly confident” that the other two charges had been proven. It also concluded unanimously that Ahluwalia had acted alone.
So he knows from research misconduct, in several of its forms. There’s one that he doesn’t seem to have engaged in, however, and that’s the one he’s decided to study in his new position at the University of East London: Continue reading Researcher found to have deceived colleague — and perhaps sabotaged others — decides to study plagiarism
Lab gadfly PETA pressures AACR, gets retraction from sanctioned scientist
People for the Ethical Treatment of Animals (PETA) may not be on most scientists’ list of Facebook friends, but we’re grateful to them for a hat tip. Several days ago, we were approached by Justin Goodman, associate director of PETA’s laboratory investigations department, with a new twist on an old story.
First, a little history: In September 2009, the Office of Research Integrity sanctioned an ex-Vanderbilt cancer researcher named Nagendra S. Ningaraj. According to the agency, Ningaraj Continue reading Lab gadfly PETA pressures AACR, gets retraction from sanctioned scientist
Some quick thoughts and links on Andrew Wakefield, the BMJ, autism, vaccines, and fraud
If you’re a savvy Retraction Watch reader — or if you’ve paid any attention at all to the news in the last 18 hours — you will have heard by now that the BMJ has called Andrew Wakefield’s work on autism and the MMR vaccine a “hoax.”
The February 2010 retraction of the original Wakefield paper in the Lancet was, of course, a huge deal. If there were a Canon of Scientific Retractions, it would be in it. It happened before we launched Retraction Watch, however, so we haven’t commented much on it.
We plan on writing about major retractions in history, but the frequency of fascinating timely ones hasn’t abated enough yet to let us do that. (One exception: Our Best of Retractions series.) And in any case, there have been a lot of pixels spilled on this one already, so we’re not sure we have much to add. That’s the nice thing about the web: It leaves us free to curate as well as create.
One comment we want to offer is that the investigation by Brian Deer in the BMJ Continue reading Some quick thoughts and links on Andrew Wakefield, the BMJ, autism, vaccines, and fraud
ORI comes down (hard) on Bengu Sezen, Columbia chemist accused of fraud
The Office of Research Integrity has thrown a heavy book at Bengu Sezen, a former chemist at Columbia University, alleging that school and agency investigators turned up 21 instances of research misconduct by the disgraced scientist.
According to the agency: Continue reading ORI comes down (hard) on Bengu Sezen, Columbia chemist accused of fraud
Best of Retractions Part III: Whatever can go wrong …
Paging Dr. Murphy.
In July, the editors of Cancer Biology & Therapy published a retraction remarkable for its scope. Apparently, nearly everything dishonest authors can do to doctor a manuscript, these authors did.
The paper, “Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma,” initially appeared on the journal’s website in January 2008. It came out in print three months later, in the April issue, and has been cited 8 times since, according to Thomson Scientific’s Web of Knowledge.
The authors were Song Zhang, Jian Xin Yue, Ju Hong Yang, Peng Cheng Cai and Wei Jia Kong, of Huazhong University of Science and Technology in Hubei, China. It will be quite clear why we listed all those authors in a moment. Continue reading Best of Retractions Part III: Whatever can go wrong …
Gene therapy researcher Savio Woo retracts two more papers
Mount Sinai School of Medicine researcher Savio Woo, whom Retraction Watch reported last week has already retracted four papers from major journals as two postdocs have been fired from his lab, has retracted two more from Molecular Therapy: The Journal of the American Society of Gene Therapy.
The two papers, both from 2007, were Continue reading Gene therapy researcher Savio Woo retracts two more papers